<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Public health collaboration &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/public-health-collaboration/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 14 Oct 2025 19:44:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Public health collaboration &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Tracking SARS-CoV-2’s Genomic Diversity in Nigeria</title>
		<link>https://bioengineer.org/tracking-sars-cov-2s-genomic-diversity-in-nigeria/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 14 Oct 2025 19:43:52 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[COVID-19 variants]]></category>
		<category><![CDATA[genomic epidemiology]]></category>
		<category><![CDATA[Genomic surveillance]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Public health collaboration]]></category>
		<category><![CDATA[SARS-CoV-2 genomic diversity]]></category>
		<category><![CDATA[vaccine efficacy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tracking-sars-cov-2s-genomic-diversity-in-nigeria/</guid>

					<description><![CDATA[In recent years, the global landscape of infectious diseases has undergone profound shifts, particularly with the emergence of SARS-CoV-2, the virus responsible for COVID-19. Among various regions, Nigeria has emerged as a focal point for studying the genomic diversity and transmission dynamics of this virus. A substantial body of research, notably encapsulated in the work [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">280892</post-id>	</item>
		<item>
		<title>BP Initiative Supports Over 10 Million Adults Managing Hypertension</title>
		<link>https://bioengineer.org/bp-initiative-supports-over-10-million-adults-managing-hypertension/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 15 Sep 2025 14:23:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cardiovascular disease prevention]]></category>
		<category><![CDATA[Evidence-based healthcare]]></category>
		<category><![CDATA[hypertension management]]></category>
		<category><![CDATA[Public health collaboration]]></category>
		<category><![CDATA[Target: BP initiative]]></category>
		<guid isPermaLink="false">https://bioengineer.org/bp-initiative-supports-over-10-million-adults-managing-hypertension/</guid>

					<description><![CDATA[In the United States, hypertension remains an omnipresent and formidable public health challenge, silently undermining the well-being of nearly half the adult population. According to the 2025 American Heart Association Statistical Update, a staggering 122.4 million U.S. adults are currently grappling with high blood pressure, a primary and modifiable risk factor linked directly to cardiovascular [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">269192</post-id>	</item>
	</channel>
</rss>
